2022 Keynote Information

Calculate. Accommodate. Innovate.

Now more than ever, the important work of this clinical research community requires collaboration and innovation. Now in its 13th year of fostering these goals, SCOPE Summit 2022 will take place February 7-10, 2022 in Orlando, FL at a new location, the Rosen Shingle Creek. Over four stimulating days of in-depth discussions in 22 different conferences, 3 plenary keynote sessions, the 6th annual Participant Engagement Awards, special cross-department panels, a first-time charity golf tournament, and the ever-popular interactive breakout discussions, the programming focuses on advances and innovative solutions in all aspects of clinical trial innovation, planning, management and operations. SCOPE Virtual 2021 attracted more than 2,200 leaders in clinical operations and research, and we look forward to you and your team joining us!

View All 22 Conference Programs | Breakouts | Participant Engagement Award



8:00am SCOPE’s Inaugural Masters of Clinical Research Golf Tournament


For more information on participating or how you can get involved as a sponsor, please visit the Masters of Clinical Research webpage.

2:00 pm Pre-Conference User Group Meeting & Hosted Workshops
Co-locate your User Group, a Workshop or even your company’s Annual Meeting with SCOPE Summit. CHI will help market the event and manage logistical operations. We will co-market to prospective attendees and extend your users a discount to attend the entire SCOPE conference. We are here to work with you. Use SCOPE as your gathering point!



5:00 Organizer's Welcome Remarks
Lieberman_MicahMicah Lieberman, Executive Director, Conferences, Cambridge Healthtech Institute (CHI)

5:05 SCOPE's Inaugural Masters of Clinical Research Golf Tournament Awards (Sponsorship Opportunity Available)

5:10 Chairperson’s Introduction: Proven Technology and Services to Support a Seamless Clinical Trial Journey for Participants
Shingler_TarraTarra Shingler, Senior Vice President, StudyKIK

5:15 Engaging and Understanding Patient Behavior to Improve Accessibility, Retention and Outcomes
Patient-centric drug development that incorporates patient experience coupled with behavioral science and real-world evidence is evolving the way in which sponsors and regulators bring new medicines to the patients. This executive panel will discuss emerging trends along with case studies that demonstrate how understanding patient need, beliefs and their healthcare journeys influences participation in clinical trials and impacts outcomes.

Irfan KhanPanel Moderator:  Irfan Khan, MD, CEO, Circuit Clinical

Victoria DiBiasoVictoria DiBiaso, Global Head, Patient Informed Development & Health Value Translation, Sanofi
Brendan O'NeillBrendan O'Neill, Senior Director Patient Recruitment Programs, Clinical Development & Operations & Global Product Development, Pfizer
Gretchen GollerGretchen Goller, Sr. Director, Head of Patient Recruitment, Clinical Development Operations, Seagen
Wolfram_ThadThad Wolfram, President, Matrix Clinical Trials

5:45 SCOPE's 2022 Participant Engagement Awards Introduction
David SallDavid Sall, President & CEO, Patient Enrollment Advisors; Co-Creator of the SCOPE Participant Engagement Award

5:50 SCOPE's 2022 Participant Engagement Awards

SCOPE's 2020 Participant Engagement Awards

Now in its 6th year, the Participant Engagement Award (PEA) recognizes innovation and change in how the industry communicates with participants in the fields of recruitment and retention in clinical trials. Submit your proposal!

David SallCHAIRPERSON: David Sall, President & CEO, Patient Enrollment Advisors; Co-Creator of the SCOPE Participant Engagement Award
Kelly McKeeKelly McKee, Vice President, Patient Recruitment and Registries, Medidata; Co-Creator of the SCOPE Participant Engagement Award
Micah LiebermanMicah Lieberman, Executive Director, Conferences, Cambridge Healthtech Institute (CHI)
Kimberly RichardsonKimberly Richardson, Research Advocate, Founder, Black Cancer Collaborative
Michelle CrouthamelMichelle Crouthamel DBA, Head, Digital Science, AbbVie
Irfan KhanIrfan Khan, MD, CEO, Circuit Clinical
Gretchen GollerGretchen Goller, Sr. Director, Head of Patient Recruitment, Clinical Development Operations, Seagen
Alicia StaleyAlicia Staley, MBA, Trial Volunteer & Cancer Survivor; Vice President, Patient Engagement, Medidata

6:35 SCOPE's Kick-Off Networking Happy Hour (Gatlin Terrace)

7:45 Close of Day

Tuesday, February 8, 2022


Morning Plenary Keynotes

7:15 am Morning Coffee (Sponsorship Opportunity Available)  

8:05 Organizer's Welcome Remarks  
Micah LiebermanMicah Lieberman, Executive Director, Conferences, Cambridge Healthtech Institute (CHI)

8:10 Chairperson’s Introduction
Peyton HowellPeyton Howell, Chief Commercial & Strategy Officer & President, Consulting, Parexel

8:15 Fireside Chat: Fit-for-Future Data Operations in a Post-Pandemic World
Demetris ZambasDemetris Zambas, Vice President & Global Head, Data Monitoring & Management, Pfizer Inc.
Darren WestonDarren Weston, Vice President, Integrated Data Analytics & Reporting (IDAR), Janssen
Cynthia PanCynthia Pan, Senior Director, Program Operations Leader, Global Clinical Operations, Regeneron
The COVID-19 pandemic continues to reshape our world and our approaches to clinical trials. During the last 20 months, the risk-benefit ratios of many innovative methodologies and technologies has inversed. Risk averse organizations have grasped the realities that these new innovative methods are now the only means to efficiently execute clinical trials.  This new reality and the ongoing need for real time data collection and consumption require new creative and live data flows. An additional ramification of this evolution has been a significant improvement in the level of collaboration required and realized within our organizations and with our external partners and technology providers. Let us discuss how we can cement this “New Normal” to not only maintain the momentum but to ensure these valuable innovations are sustainable.

  • Summary of the experience in delivering critical treatments/vaccines in response to a public healthcare crisis
  • How did the Risk-benefit dynamic drive innovation or the implementation of innovations in your COVID19 trials and/or other trials during the pandemic?
  • Were there any note-worthy cross-functional collaboration dynamics?
  • What do you feel were the most impactful innovations leveraged (could be process or technology)?
  • Were you able to leverage data in new creative ways to gain more value in execution/operations?
  • What do you think will stay with us from the innovations as our new normal going forward?

9:10 Case Study: Moving Beyond the Promise of Connected Health, Learning from Implementation at Scale
Justin WrightJustin Wright, Vice President, Global Head Connected Health, Novartis
Adama IbrahimAdama Ibrahim, EMBA, Director, Digital Solutions, Novartis
At Novartis Global Drug Development, we have a vision to accelerate digital products by developing one or more “connected health” solutions (connected device, wearable, software as a medical devices) into our drug programs over the next 5 years. This showcase of the Connected Health group, formed to deliver the vision, will focus on presenting the real work that has been done as a collaboration to bring these digital health tools to clinicians, patients and to pharma research that improve the overall health care experience and improve access to trials. How does an integrated patient experience deliver more value to patients, providers and payers? How do you give patients their own digital data so they can be more engaged in their treatment plans? How can Connected Health improve clinical workflow, communication, data exchange and clinical research? How do you do this at scale, beyond a pilot?

9:55 Grand Opening Coffee Break in the Exhibit Hall

WEDNesday, February 9, 2022


Afternoon Plenary Keynotes

1:30 pm Welcome Remarks from CHI and The SCOPE Team
Micah Lieberman, Dr. Marina Filshtinsky, Kaitlin Kelleher, Bridget Kotelly, Mary Ann Brown, Ilana Quigley, Patty Rose, Julie Kostas, and Tricia Michalovicz

1:40 Why Advancing Inclusive Research Is a Moral, Scientific and Business Imperative
Meghan McKenzieMeghan McKenzie, Principal,  Inclusion, Patient Insights and Health Equity, Chief Diversity Office, Genentech
Our industry is rightfully focused on the importance of diversity, equity and inclusion in clinical trials. Many of us have been focused on this in our work and/or in our advocacy, both inside and outside of our organizations for some time. Why is inclusivity so important to PIs and patients? Why is it both a moral and a business imperative? Learn why representation in clinical research matters for your patients and how it shapes good science. The face of the world is changing and your success is tied to reaching ethnic minorities.

2:00 Panel Discussion: Implicit Bias Around Advocacy and Decision Making: Metrics of DE&I and Speaking the Language of Business and Leadership
Kimberly RichardsonPanel Moderator: Kimberly Richardson, Research Advocate, Founder, Black Cancer Collaborative
Karriem WatsonKarriem Watson, PhD, Chief Engagement Officer, NIH
Monique PhillipsMonique Phillips, Clinical Trial Recruitment Specialist, Bristol Myers Squibb
Nikhil WagleNikhil Wagle, MD, Assistant Professor, Harvard Medical School, Dana-Farber Cancer Institute
What is the perspective of Black professionals and patient advocates as the medical and scientific industries grapple with effective ways to engage minority population? Where are their voices being heard and what can we learn from the cultural experiences they weave into their research methodologies and daily practices? Panelists will share their perspectives on how the Black voice should be included in advocacy and public and private aspects of clinical research. 

2:45 Booth Crawl & Refreshment Break in the Exhibit Hall (Sponsorhip Opportunity Available).

SCOPE of Things Podcast